CryoPort Inc (CYRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -149.297 | -55.674 | -24.858 | -19.046 | -21.802 | -34.073 | -4.214 | -10.778 |
Return on Equity (%) | -237.078 | -67.034 | -33.866 | -22.243 | -29.482 | -55.386 | -7.57 | -20.594 |
Return on Invested Capital (%) | -142.748 | -69.156 | -24.586 | -19.466 | -5.597 | -0.706 | -1.851 | -5.652 |
Operating Margin (%) | -168.855 | -65.903 | -48.237 | -49.8 | -38.348 | -120.909 | -12.202 | -40.233 |
Net Profit Margin (%) | -169.9 | -66.078 | -48.691 | -54.007 | -95.34 | -127.455 | -19.106 | -46.124 |
Book Value Per Share | 0.305 | 0.667 | 1.227 | 2.873 | 0.506 | 5.684 | 4.027 | 3.254 |
Earnings Per Share | -0.559 | -0.296 | -0.305 | -0.478 | -1.838 | -5.695 | -0.934 | -2.188 |
Cash Per Share | 0.243 | 0.564 | 1.192 | 1.232 | 0.903 | 2.792 | 0.754 | 0.943 |
Working Capital Per Share | 0.208 | 0.566 | 1.556 | 2.544 | 2.747 | 13.066 | 11.607 | 9.957 |
Operating Profit Per Share | 0.152 | 0.248 | 0.354 | 0.516 | 1.132 | 2.344 | 2.61 | 2.58 |
EBIT Per Share | -0.559 | -0.296 | -0.305 | -0.477 | -0.802 | -5.497 | -0.723 | -2.021 |
EBITDA Per Share | -0.559 | -0.296 | -0.305 | -0.477 | -0.802 | -5.497 | -0.723 | -2.021 |
Free Cash Flow Per Share | -0.54 | -0.253 | -0.238 | -0.4 | -1.843 | -5.599 | -0.905 | -1.834 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 17,6M | 25,7M | 30,32M | 37,34M | 39,84M | 49,62M | 48,33M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 48,33M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -5.688 | N/A | N/A | N/A | -31.767 | N/A | N/A |
Net Profit Margin (%) | N/A | -12.057 | N/A | N/A | N/A | -38.275 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 394,46M |
Ratio cours/bénéfice | -3,9 |
Ratio prix/ventes | 1,8 |
Ratio prix/liquidités | 9,06 |
Ratio prix/valeur comptable | 0,86 |
Rendement de dividende | - |
Actions en circulation | 49,43M |
Volume moyen (1 semaine) | 217k |
Volume moyen (1 mois) | 324,01k |
Variation sur 52 semaines | -43,85% |
Plus haut sur 52 semaines | 20,105 |
Plus bas sur 52 semaines | 5,315 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales